Stocks in play: Avalon GloboCare Corp.
Announced that Laboratory Services MSO, LLC is now offering an in-house laboratory developed test to detect Tuberculosis using a patient’s sputum sample. Avalon owns a 40% interest in LSM. LSM’s new polymerase chain reaction test allows for accurate and rapid identification of Mycobacterium tuberculosis from samples. The use of sputum samples to detect Mtb provides easier collection and transport than blood samples, which are used in protein-based chemiluminescent immuno-assays. Avalon GloboCare Corp. shares N.ALBT are trading unchanged at $0.94.
Read:
Novel Mechanisms Leading the Charge in Fight Against Cancer, Opening Door to New Drugs & Therapies
Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023
Promising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting
Global Lithium Supply Under Pressure as South American Nations Discuss "Lithium OPEC"